Rougeron V., Elguero Eric, Arnathau C., Hidalgo B. A., Durand P., Houze S., Berry A., Zakeri S., Haque R., Alam M. S., Nosten F., Severini C., Woldearegai T. G., Mordmuller B., Kremsner P. G., Gonzalez-Ceron L., Fontecha G., Gamboa D., Musset L., Legrand E., Noya O., Pumpaibool T., Harnyuttanakorn P., Lekweiry K. M., Albsheer M. M., Hamid M. M. A., Boukary Aoms, Trape Jean-François, Renaud F., Prugnolle F. (2020). Human Plasmodium vivax diversity, population structure and evolutionary origin. PLoS Neglected Tropical Diseases, 14 (3), e0008072 [17 p.]. ISSN 1935-2735.
Titre du document
Human Plasmodium vivax diversity, population structure and evolutionary origin
Année de publication
2020
Auteurs
Rougeron V., Elguero Eric, Arnathau C., Hidalgo B. A., Durand P., Houze S., Berry A., Zakeri S., Haque R., Alam M. S., Nosten F., Severini C., Woldearegai T. G., Mordmuller B., Kremsner P. G., Gonzalez-Ceron L., Fontecha G., Gamboa D., Musset L., Legrand E., Noya O., Pumpaibool T., Harnyuttanakorn P., Lekweiry K. M., Albsheer M. M., Hamid M. M. A., Boukary Aoms, Trape Jean-François, Renaud F., Prugnolle F.
Source
PLoS Neglected Tropical Diseases, 2020,
14 (3), e0008072 [17 p.] ISSN 1935-2735
Author summary Among the five Plasmodium species infecting humans, P. vivax is the most prevalent parasite outside Africa. To date, there has been less research on this species than for Plasmodium falciparum, a more lethal species, principally because of the lack of an in vitro culture system and also because P. vivax is considered relatively benign. Nevertheless, P. vivax is responsible for severe and incapacitating clinical symptoms with significant effects on human health. The emergence of new drug resistance and the discovery of severe and even fatal cases due to P. vivax question the benign status of P. vivax malaria. In recent years, there has been increased interest in characterizing the distribution of genetic variation in P. vivax. However, these studies either generated genetic information from a regional geographic scale or combine genetic datasets generated in different molecular platforms, which is known to generate biased results. In this study, we used a single genotyping platform to genotype 14 microsatellite markers in 834 samples of P. vivax obtained from 28 locations in 20 countries from around the world, including several populations from East and West Africa. We discuss the worldwide population genetic structure and the evolutionary origins of P. vivax, as well as its introduction into the Americas. More than 200 million malaria clinical cases are reported each year due to Plasmodium vivax, the most widespread Plasmodium species in the world. This species has been neglected and understudied for a long time, due to its lower mortality in comparison with Plasmodium falciparum. A renewed interest has emerged in the past decade with the discovery of antimalarial drug resistance and of severe and even fatal human cases. Nonetheless, today there are still significant gaps in our understanding of the population genetics and evolutionary history of P. vivax, particularly because of a lack of genetic data from Africa. To address these gaps, we genotyped 14 microsatellite loci in 834 samples obtained from 28 locations in 20 countries from around the world. We discuss the worldwide population genetic structure and diversity and the evolutionary origin of P. vivax in the world and its introduction into the Americas. This study demonstrates the importance of conducting genome-wide analyses of P. vivax in order to unravel its complex evolutionary history.
Plan de classement
Sciences fondamentales / Techniques d'analyse et de recherche [020]
;
Entomologie médicale / Parasitologie / Virologie [052]
Description Géographique
CAMEROUN ; ETHIOPIE ; MAURITANIE ; SOUDAN ; TOGO ; MEXIQUE ; HONDURAS ; VENEZUELA ; PEROU ; GUYANE FRANCAISE ; ARMENIE ; AZERBAIDJAN ; IRAN ; PAKISTAN ; TURQUIE ; BANGLADESH ; LAOS ; INDE ; THAILANDE
Localisation
Fonds IRD [F B010079054]
Identifiant IRD
fdi:010079054
